Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 93 results found. Search for [ CanSino ]

Results 1 to 21 of 93
Reuters
June 5, 2021
China's mass vaccination drive, which administered 723.5 million doses of vaccines as of June 3, is currently only open to those aged 18 and above


Reuters
June 1, 2021
WHO will also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which faces major supply problems due to an Indian export suspension


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


PTI
April 9, 2021
Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac


BusinessToday.In
March 16, 2021
'Foreigners who are flying from India to China will be required to present the Electronic Health Declaration for boarding. Foreign Passengers can apply for the Electronic Health Declaration Form,' the embassy said


Associated Press
March 13, 2021
Although emergency vaccinations have been underway in China since at least last summer, the country has been slow to announce whether it had any plans to achieve herd immunity


PTI
March 5, 2021
National Health Service (NHS) Secretary Amir Ashraf Khawaja while briefing the Public Accounts Committee on Thursday said that the Pakistan government has no plan to buy vaccines anytime soon


PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


Reuters
February 9, 2021
Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people


Reuters
January 30, 2021
Mexico is trying to secure as much vaccine supply as possible amid delivery delays and a surge in cases. Mexico's death toll from COVID-19 was 156,579 on Friday


PTI
December 20, 2020
Spokespeople for Pfizer, Moderna and AstraZeneca have said that pork products are not part of their COVID-19 vaccines. But limited supply and preexisting deals worth millions of dollars with other companies means that some countries with large Muslim populations, such as Indonesia, will receive vaccines that have not yet been certified to be gelatin-free


Reuters
November 18, 2020
The Sinovac findings, published in a peer-reviewed paper in medical journal The Lancet Infectious Diseases, came from results in Phase I and Phase II clinical trials in China involving more than 700 participants


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Reuters
September 26, 2020
China launched its emergency programme in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official


Associated Press
September 25, 2020
Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


Reuters
September 15, 2020
A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech are developing the three vaccines under the state's emergency use programme


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


PAGES 1 OF 5  12345